Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-005465
Filing Date
2025-02-13
Accepted
2025-02-13 17:09:20
Documents
1
Period of Report
2025-02-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1739484553.html 4  
1 FORM 4 wk-form4_1739484553.xml 4 4712
  Complete submission text file 0001628280-25-005465.txt   6188
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Issuer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 700 US HIGHWAY 202/206 BRUDGEWATER NJ 08807
Business Address
Bonstein Sara (Reporting) CIK: 0001604019 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30739 | Film No.: 25621501